| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Bicara Therapeutics Inc. | Director | Stock Option (Right to Buy) | 23,746 | 09 Jun 2025 | Direct | ||
| DICE Therapeutics, Inc. | CFO & CBO | Common Stock | 0 | $46.50 | 09 Aug 2023 | Direct | |
| DICE Therapeutics, Inc. | CFO & CBO | Restricted Stock Units | 0 | 09 Aug 2023 | Direct | ||
| DICE Therapeutics, Inc. | CFO & CBO | Stock Option (right to buy) | 0 | 09 Aug 2023 | Direct |